Skip to main content
logo
BioVersys AG (SWX:BIOV)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
24.80
-0.40 (-1.59%)
At close: Aug 21, 2026

BioVersys AG Ratios and Metrics

Millions CHF. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Market Capitalization
145143--
Market Cap Growth
-3.19%---
Enterprise Value
8569--
Last Close Price
24.8024.40--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
PS Ratio
45.8144.94--
PB Ratio
2.432.39--
P/TBV Ratio
2.432.39--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
26.6721.69--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.360.361.591.86
Net Debt / Equity Ratio
-1.02-1.02-1.46-1.45
Net Debt / EBITDA Ratio
3.063.060.840.71
Net Debt / FCF Ratio
2.742.741.001.06
Asset Turnover
0.050.050.04-
Quick Ratio
9.559.553.513.25
Current Ratio
10.1010.103.563.59
Return on Equity (ROE)
-61.93%-61.93%-194.40%-
Return on Assets (ROA)
-19.87%-19.87%-33.86%-
Return on Capital Employed (ROCE)
-24.40%-24.40%-74.00%-71.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-15.01%-15.30%--
FCF Yield
-15.24%-15.53%--
Buyback Yield / Dilution
-68.49%-68.49%-11.60%-